Rosuvastatin
Infarction, Anterior Cerebral Artery
Second Affiliated Hospital of Soochow UniversitySmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Infarction, Anterior Cerebral Artery cohort.
Same molecule, other indications
Rosuvastatin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →